Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 492 entries
View as:

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT06794073 Org: User:
Start: 02/28/25 End: 06/30/27 Due: 06/30/28

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06728618 Org: User:
Start: 12/31/24 End: 03/31/28 Due: 03/31/29

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT06946849 Org: User:
Start: 06/01/25 End: 05/31/27 Due: 05/31/28

Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC

Phase: N/A Priority: Normal
NCT ID: NCT06361758 Org: User:
Start: 05/31/24 End: 05/31/27 Due: 05/31/28

Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC

Phase: N/A Priority: Normal
NCT ID: NCT06637163 Org: User:
Start: 10/24/24 End: 04/30/27 Due: 04/30/28

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Phase: N/A Priority: Normal
NCT ID: NCT05994001 Org: User:
Start: 08/01/23 End: 08/01/26 Due: 08/01/27

The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation

Phase: N/A Priority: Normal
NCT ID: NCT04501900 Org: User:
Start: 10/31/20 End: 04/30/26 Due: 04/30/27

China Valve Registry Study-1

Phase: N/A Priority: Normal
NCT ID: NCT02623907 Org: User:
Start: 05/31/16 End: 05/31/20 Due: 05/31/21

ERAS in Video-assisted Mediastinal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03271606 Org: User:
Start: 08/23/17 End: 02/23/18 Due: 02/23/19

Near-infrared Vision for Microcirculatory Status

Phase: N/A Priority: Normal
NCT ID: NCT04399811 Org: User:
Start: 05/17/20 End: 12/31/23 Due: 12/31/24

The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT02695732 Org: User:
Start: 12/31/15 End: 09/30/18 Due: 09/30/19

The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT04221672 Org: User:
Start: 11/07/19 End: 12/30/20 Due: 12/30/21

PIFR-based Inhalation Therapy in Patients Recovering From AECOPD

Phase: N/A Priority: Normal
NCT ID: NCT04000958 Org: User:
Start: 09/01/19 End: 07/01/21 Due: 07/01/22

Sleep Disorders and Tumor Immune Microenvironment

Phase: N/A Priority: Normal
NCT ID: NCT06941948 Org: User:
Start: 05/01/25 End: 01/01/28 Due: 01/01/29

Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06941987 Org: User:
Start: 04/20/25 End: 10/20/27 Due: 10/20/28

the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02385578 Org: User:
Start: 03/31/15 End: 06/30/16 Due: 06/30/17

Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02908204 Org: User:
Start: 10/31/16 End: - Due: -

Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04004793 Org: User:
Start: 06/12/20 End: 01/31/23 Due: 01/31/24

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06599775 Org: User:
Start: 10/31/24 End: 10/31/28 Due: 10/31/29

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC

Phase: N/A Priority: Normal
NCT ID: NCT06599827 Org: User:
Start: 09/20/24 End: 09/20/29 Due: 09/20/30

Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions

Phase: N/A Priority: Normal
NCT ID: NCT06705036 Org: User:
Start: 11/01/24 End: 12/31/26 Due: 12/31/27

Transparent Cap-assisted Endoscopic Sclerotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02361593 Org: User:
Start: 04/30/15 End: 12/31/16 Due: 12/31/17

Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06991829 Org: User:
Start: 04/03/25 End: 10/31/27 Due: 10/31/28

A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia

Phase: N/A Priority: Normal
NCT ID: NCT06992011 Org: User:
Start: 02/01/23 End: 02/28/27 Due: 02/28/28

A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.

Phase: N/A Priority: Normal
NCT ID: NCT05386420 Org: User:
Start: 05/23/22 End: 11/15/22 Due: 11/15/23